JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB5475

Anti-VEGF Receptor 2 (phospho Y1214)抗体

Anti-VEGF Receptor 2 (phospho Y1214) antibody

Be the first to review this product! Submit a review

|

(11 Publications)

Rabbit Polyclonal VEGF Receptor 2 phospho Y1214 antibody. Suitable for WB and reacts with Synthetic peptide - Human, Human samples. Cited in 11 publications.

查看别名

CD309, FLK1, VEGFR2, KDR, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, FLK-1

2 Images
Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)
  • WB

Unknown

Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)

Peptide Competition and Stimulation : Extracts prepared from CSF-1 stimulated (1-4, 6) or unstimulated (5) PAE cells transfected with a chimeric CSF-1/VEGFR2 receptor were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4°C, then were incubated with 0.50 μg/mL ab5475 antibody for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with : no peptide (1, 5, 6), the nonphosphopeptide corresponding to the immunogen (2), a generic phosphotyrosine containing peptide (3), or, the phosphopeptide immunogen (4). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase and bands were detected using the Tropix WesternStar method. The data show that only the peptide corresponding to ab5475 blocks the antibody signal, and the stimulation of the phospho signal after stimulating ligand is added (CSF-1 for the chimeric r

All lanes:

Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (ab5475)

Predicted band size: 151 kDa

false

Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)
  • WB

Supplier Data

Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)

Modulation of expression of target protein by cell treatment to demonstrate antibody specificity.

The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate

All lanes:

Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (ab5475) at 1/1000 dilution

Lane 1:

HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate at 30 µg

Lane 2:

HT-29 Serum Starved followed by treatment for 10 minutes with 100 ng/mL of SCF at 30 µg

Lane 3:

Caco-2 (Human colorectal adenocarcinoma cell line) whole cell lysate at 30 µg

Lane 4:

Caco-2 Serum Starved followed by treatment for 10 minutes with 100 ng/mL of SCF at 30 µg

Secondary

All lanes:

Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/5000 dilution

Predicted band size: 151 kDa

Observed band size: ~151 kDa

false

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特异性

VEGFR3 has not been tested, but is expected to react.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.35000-1 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Synthetic peptide - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.35000-1 µg/mL", "WB-species-notes": "<p></p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
纯化说明
The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated VEGFR 2 protein. The final product is generated by affinity chromatography using a VEGFR 2 derived peptide that is phosphorylated at Tyrosine 1214.
存储溶液
pH: 7.3 Preservative: 0.05% Sodium azide Constituents: PBS, 0.1% BSA
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

VEGF Receptor 2 also known as KDR or Flk-1 is a receptor tyrosine kinase important for mediating the effects of vascular endothelial growth factor (VEGF). This protein has a mass of approximately 150 kDa. It mostly expresses in vascular endothelial cells playing a primary role in the formation of blood vessels. The receptor can also be found in various non-endothelial tissues though in smaller amounts indicating its broad functional roles outside of the vascular system.
Biological function summary

VEGF Receptor 2 is important for angiogenesis and vascular permeability. It is part of the VEGF receptor family which also includes VEGF Receptors 1 and 3 forming a complex interaction network. Upon binding with VEGF it phosphorylates key proteins to initiate signals that regulate endothelial cell migration proliferation and survival. The receptor's function is critical for normal developmental processes and wound healing as well.

Pathways

VEGF Receptor 2 is especially important within the angiogenesis and vascular permeability pathways. It plays a central role in the VEGF signaling pathway alongside proteins like VEGF A which is the primary ligand for the receptor. The signaling through this receptor modulates various downstream proteins through phosphorylation linking it to pathways that control cellular responses essential for blood vessel formation and maintenance.

VEGF Receptor 2 is significantly linked with cancer and age-related macular degeneration. In the context of cancer the overexpression or dysregulation of VEGF and its receptors including VEGF Receptor 2 often leads to enhanced tumor angiogenesis promoting tumor growth and metastasis. Additionally the receptor interacts with other proteins in pathological states such as CD309 in endothelial cell-based assays which are used for research like flow cytometry and ELISA to monitor VEGF Receptor 2 activity and its impact on diseases.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Isoform 2 plays an important role as negative regulator of VEGFA- and VEGFC-mediated lymphangiogenesis by limiting the amount of free VEGFA and/or VEGFC and preventing their binding to FLT4. Modulates FLT1 and FLT4 signaling by forming heterodimers. Binding of vascular growth factors to isoform 1 leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, reorganization of the actin cytoskeleton and activation of PTK2/FAK1. Required for VEGFA-mediated induction of NOS2 and NOS3, leading to the production of the signaling molecule nitric oxide (NO) by endothelial cells. Phosphorylates PLCG1. Promotes phosphorylation of FYN, NCK1, NOS3, PIK3R1, PTK2/FAK1 and SRC.
See full target information KDR phospho Y1214

文献 (11)

Recent publications for all applications. Explore the full list and refine your search

Annals of translational medicine 9:1743 PubMed35071437

2022

Notoginsenoside R2 induces colonic microvascular injuries via regulating the Rap1GAP/PI3K/Akt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ping Tao,Jiang Lin,Beiping Zhang,Shiying Wang

The Journal of biological chemistry 295:11466-11472 PubMed32518161

2020

Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Hu,Hongyan Li,Zhiping Chi,Jianbo He

Cell death & disease 10:131 PubMed30755600

2019

P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxiang Chen,Kaixuan Zeng,Mu Xu,Xiangxiang Liu,Xiuxiu Hu,Tao Xu,Bangshun He,Yuqin Pan,Huiling Sun,Shukui Wang

FASEB journal : official publication of the Federa 31:2001-2012 PubMed28183800

2017

TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Gui-Li Yang,Zilong Zhao,Ting-Ting Qin,Dong Wang,Lijuan Chen,Rong Xiang,Zhen Xi,Rongcai Jiang,Zhi-Song Zhang,Jianning Zhang,Lu-Yuan Li

Developmental biology 408:41-55 PubMed26455409

2015

The endocytic recycling regulatory protein EHD1 Is required for ocular lens development.

Applications

Unspecified application

Species

Unspecified reactive species

Priyanka Arya,Mark A Rainey,Sohinee Bhattacharyya,Bhopal C Mohapatra,Manju George,Murali R Kuracha,Matthew D Storck,Vimla Band,Venkatesh Govindarajan,Hamid Band

Journal of neuroinflammation 10:11 PubMed23339567

2013

Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats.

Applications

IHC

Species

Unspecified reactive species

Yu-Wen Hung,Ming-Tsong Lai,Yi-Jhan Tseng,Chien-Chen Chou,Yung-Yang Lin

Developmental dynamics : an official publication o 241:684-96 PubMed22354878

2012

In vivo Notch reactivation in differentiating cochlear hair cells induces Sox2 and Prox1 expression but does not disrupt hair cell maturation.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiyong Liu,Thomas Owen,Jie Fang,R Sathish Srinivasan,Jian Zuo

The Journal of clinical endocrinology and metaboli 96:E1973-81 PubMed21994955

2011

Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.

Applications

WB, IHC

Species

Human, Human

Anniina Färkkilä,Marjut Pihlajoki,Hanna Tauriala,Ralf Bützow,Arto Leminen,Leila Unkila-Kallio,Markku Heikinheimo,Mikko Anttonen

BMC developmental biology 10:13 PubMed20105280

2010

Activated Ras alters lens and corneal development through induction of distinct downstream targets.

Applications

IHC

Species

Unspecified reactive species

Daniel Burgess,Yan Zhang,Ed Siefker,Ryan Vaca,Murali R Kuracha,Lixing Reneker,Paul A Overbeek,Venkatesh Govindarajan

Journal of chromatography. B, Analytical technolog 867:62-8 PubMed18396113

2008

A simple method for obtaining transferrins from human plasma and porcine serum: preparations and properties.

Applications

Unspecified application

Species

Unspecified reactive species

Lin Wu,Jinhui Wu,Jian Zhang,Yuanyuan Zhou,Guoyan Ren,Yiqiao Hu
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

关联产品

Select an associated product type
Alternative Product
Primary Antibodies

AB237634

Anti-VEGF Receptor 2 antibody [EPR21233]

primary-antibodies

vegf-receptor-2-antibody-epr21233-ab237634

0

(0 reviews)

Alternative Product
Primary Antibodies

AB134191

Anti-VEGF Receptor 2 antibody [EPRER16Y]

primary-antibodies

vegf-receptor-2-antibody-eprer16y-ab134191

0

(0 reviews)

Alternative Product
Primary Antibodies

AB234106

Anti-VEGF Receptor 2 antibody [EPR21884-236] - BSA and Azide free

primary-antibodies

vegf-receptor-2-antibody-epr21884-236-bsa-and-azide-free-ab234106

0

(0 reviews)

Alternative Product
Primary Antibodies

AB233693

Anti-VEGF Receptor 2 antibody [EPR21884-236]

primary-antibodies

vegf-receptor-2-antibody-epr21884-236-ab233693

0

(0 reviews)

Alternative Product
Primary Antibodies

AB221679

Anti-VEGF Receptor 2 antibody [EPR21884-290]

primary-antibodies

vegf-receptor-2-antibody-epr21884-290-ab221679

0

(0 reviews)

Alternative Product
Primary Antibodies

AB234110

Anti-VEGF Receptor 2 antibody [EPR21231]

primary-antibodies

vegf-receptor-2-antibody-epr21231-ab234110

3

(1 reviews)

Alternative Product
Primary Antibodies

AB226160

Anti-VEGF Receptor 2 antibody [EPRER16Y] - BSA and Azide free

primary-antibodies

vegf-receptor-2-antibody-eprer16y-bsa-and-azide-free-ab226160

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com